相关实验视频
Updated: Jan 18, 2026

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.5K
在侵袭性甲状腺癌细胞中ETV5/p38信号轴的作用
Jerry H Houl1, Rozita Bagheri-Yarmand1, Muthusamy Kunnimalaiyaan1
1Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Molecular cancer therapeutics
|January 16, 2026
概括
通过像达布拉费尼布这样的BRAF抑制剂准p38通路显示出对侵袭性甲状腺癌 (PDTC和ATC) 的承诺. 这种组合疗法可以克服耐药性,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 差差分化的甲状腺癌 (PDTC) 和形甲状腺癌 (ATC) 的预后不佳.
- BRAFV600E突变激活了MAPK,推动了癌症的生长,但对抑制剂产生了耐药性.
- 在PDTC/ATC中,ETV5表达与BRAFV600E相关,这表明ETV5在通路激活中的作用.
研究的目的:
- 研究攻击性甲状腺癌中ETV5,p38和MAPK通路之间的联系.
- 评估将p38抑制剂与BRAF抑制剂dabrafenib结合使用的疗效.
- 探索治疗策略,以克服PDTC和ATC中的抵抗.
主要方法:
- 分析了ETV5表达及其与p38通路激活的关联.
- 降低ETV5水平,以评估对p38和上游监管机构的影响 (MKK3/MKK6).
- 在试验室和小鼠模型中进行了p38抑制剂与达布拉费尼布结合的高通量选.
主要成果:
- ETV5表达与p38激活相关;减少ETV5降低了p38的信号传递.
- 结合p38和BRAF抑制显示出强大的协同作用,克服TP53突变细胞中的抵抗.
- 组合疗法在ATC的临床前小鼠模型中显示出有效性.
结论:
- 在侵袭性甲状腺癌中,MAPK和p38/MAPK14通路是相互连接和致癌的.
- 将p38抑制剂与达布拉费尼布结合在一起,为PDTC和ATC提供了潜在的治疗策略.
- 需要开发更具特异性的p38抑制剂,以最大限度地提高治疗效益.
相关概念视频
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Synthesis and Regulation of Thyroid Hormones
7.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

